Compare Deutsche Bank AG (DB) vs Elevance Health Inc. Common Stock (ELV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Elevance Health Inc. Common Stock — how do they compare? Deutsche Bank AG trades at $33.61 (market cap $62.42B), while Elevance Health Inc. Common Stock trades at $401.8 (market cap $86.95B). The key difference: Elevance Health Inc. Common Stock is the larger of the two by market cap, and Deutsche Bank AG pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| DB | ELV | |
|---|---|---|
Market Cap | $62.42B | $86.95B |
Volume | 2,918,760 | 782,706 |
Sector | Financials | Health |
52-Week High | $41.56 | $426.79 |
52-Week Low | $28.37 | $280.74 |
Typical Hold Time | 80 Days | — |
Enterprise Value | $77.06B | $107.76B |
Dividend Yield | 3.46% | 1.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deutsche Bank (DB) trades at $33.55, down 4.5% amid concerns over Q3 investment banking revenue. The stock shows attractive valuation with P/E of 9.1 and P/B of 0.71, while fundamentals improved with 2025 net income reaching $6.93B. Technical indicators signal bearish momentum with price near support at $33. Recent news highlights management's focus on 2028 targets and wealth management growth.
The outlook remains mixed - strong fundamentals and undervaluation present opportunity, but near-term headwinds in investment banking and bearish technicals suggest caution. Key risks include revenue volatility and European economic pressures, while analyst consensus leans neutral with 57.6% hold ratings.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Elevance Health Inc. Common Stock
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →
